gadoxetate disodium (eovist) Report issue

Small molecule Approved FDA
AACT ChEMBL DrugBank Drug Central Drugs@FDA KEGG MeSH PubChem

Active Ingredient History

NOW
  • Now
Gadoxetic acid is a gadolinium-based MRI contrast agent. Its salt, gadoxetate disodium, is marketed as Primovist in Europe and Eovist in the United States by Bayer HealthCare Pharmaceuticals.   Wikipedia

Chemistry

More Chemistry

Pharmacology

  • Mechanisms of Action:
  • Multi-specific: Missing data
  • Black Box: No
  • Availability: Prescription Only
  • Delivery Methods: Missing data
  • Pro Drug: No

Drug Pricing (per unit)

United States

$105.5720 - $190.0040
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

Alternative names

disodium gadoxetate | eovist | gadolinium (4s)-4-(4-ethoxybenzyl)-3,6,9-tris(carboxylatomethyl)-3,6,9-triazaundecanoic acid disodium salt | gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid | gadolinium ethoxybenzyl dtpa | gadoxetate | gadoxetate disodium | gadoxetic acid | gadoxetic acid disodium | gd-eob-dtpa | primovist | zk-139834

Organizations (22)

Research & Development (22)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (1)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (17)

Approved Indications (2)


 

Diagnostic Imaging (approved 2008)

Liver Diseases

Experimental Indications - Clinical Trial Phases 1-4 (16)


 

Arteries (Phase 4)

Carcinoma, Hepatocellular (Phase 4)

Cognition (Phase 4)

Colorectal Neoplasms (Phase 4)

Contrast Media (Phase 4)

Fibrosis (Phase 4)

Liver (Phase 1/Phase 2)

Liver Diseases (Phase 3)

Liver Neoplasms (Phase 1)

Magnetic Resonance Imaging (Phase 3)

Motor Activity (Phase 4)

Neoplasm Metastasis (Phase 4)

Pharmacokinetics (Phase 1/Phase 2)

Prostatic Neoplasms (Phase 2)

Prostatic Neoplasms, Castration-Resistant (Early Phase 1)

Sports Medicine (Phase 1/Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 17
  • # of Trial Organizations: 22

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue